Search

10 results on this page

癌症定制疫苗首度闖過III期

癌症定制疫苗首度闖過III期

Merck與Moderna宣布,個性化腫瘤疫苗intismeran autogene在黑色素瘤III期試驗中取得陽性結果,與PD-1抑制劑聯用可顯著改善無復發生存期及無遠處轉移生存期。該療法利用患者腫瘤突變資料與AI篩選新生抗原,為每位患者製作專屬mRNA疫苗。

虎嗅Media11h ago#cancer-vaccine#neoantigen#mrna
Why Long-Form Video Resists Full AI

Why Long-Form Video Resists Full AI

Long-form audiences remain highly sensitive to visible AI flaws, making full-stack AI production risky for films and television. Industry leaders are instead adopting human-led workflows where AI supports visual effects, previsualization, cleanup, quality control, and other production bottlenecks.

Nokia Shrinks China Footprint, Risks AI-RAN Data

Nokia Shrinks China Footprint, Risks AI-RAN Data

Nokia is reportedly planning further layoffs, facility closures, and a major reduction of its mainland China operations, potentially retaining only limited after-sales services. The retreat is part of a global restructuring toward AI and cloud businesses, but it may reduce Nokia’s access to China’s large-scale 5G deployment data needed for AI-RAN and future 6G research.

虎嗅Media17h ago#telecom-ai#network-data#6g
Page 3